Sanofi SA
PAR:SAN
Sanofi SA
PAR:SAN
Price:
91.3 EUR
-0.65%
Market Closed
Updated:
May 5, 2024
Sanofi SA
Revenue
|
Sanofi SA
Revenue Peer Comparison
Comparables:
IPN
VETO
VIRP
BOI
MEDCL
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sanofi SA
PAR:SAN
|
Revenue
€46.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-2%
|
|
|
Ipsen SA
PAR:IPN
|
Revenue
€3.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Vetoquinol SA
PAR:VETO
|
Revenue
€525.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
Virbac SA
PAR:VIRP
|
Revenue
€1.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Boiron SA
PAR:BOI
|
Revenue
€517.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
Medincell SA
PAR:MEDCL
|
Revenue
€9.9m
|
CAGR 3-Years
51%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
Sanofi SA
Revenue Breakdown
Breakdown by Geography
Sanofi SA
Sanofi SA
|
Total Revenue:
46.4B
EUR
|
|
Reportable Geographical Zones:
43B
EUR
|
|
North America:
19B
EUR
|
|
Other Countries:
14B
EUR
|
|
France:
2.3B
EUR
|
Breakdown by Segments
Sanofi SA
Sanofi SA
Not Available
See Also
What is Sanofi SA's Revenue?
Revenue
46.4B
EUR
46.4B
EUR
Based on the financial report for Dec 31, 2023, Sanofi SA's Revenue amounts to 46.4B EUR.
What is Sanofi SA's Revenue growth rate?
Revenue CAGR 10Y
-2%
-2%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Sanofi SA have been 8% over the past three years , 5% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
